Virology and Molecular medicine

The Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.

Antiviral drugs are a class of medication used specifically for treating viral infections. DNA immunization is a novel technique used to efficiently stimulate humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or attenuated viruses. Oncolytic virotherapy is an emerging treatment modality which uses replication competent viruses to destroy cancers. 

Advances in the past two years include preclinical proof of feasibility for a single-shot virotherapy cure, identification of drugs that accelerate intratumoral virus propagation, new strategies to maximize the immunotherapeutic potential of oncolytic virotherapy, and clinical confirmation of a critical viremic threshold for vascular delivery and intratumoral virus replication.

  • Oncolytic virotherapy
  • Viral immunotherapy
  • DNA Immunization
  • Antigen presenting cell-targeted therapy
  • Antiviral drugs and adjuvants

Related Conference of Virology and Molecular medicine

Virology and Molecular medicine Conference Speakers